Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12607000067471
Ethics application status
Approved
Date submitted
29/06/2006
Date registered
22/01/2007
Date last updated
4/01/2010
Type of registration
Retrospectively registered

Titles & IDs
Public title
A randomised controlled trial of the Practitioner Asthma Communication and Education (PACE) Australia Program
Scientific title
A randomised controlled trial to measure the impact of the Practitioner Asthma Communication and Education (PACE) Australia program on the process and outcomes of general practioners' management of children with asthma
Universal Trial Number (UTN)
Trial acronym
PACE Australia Phase 3
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Childhood asthma 1558 0
Condition category
Condition code
Respiratory 1658 1658 0 0
Asthma

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
The PACE Australia intervention for General Practitioners (GPs) comprised two structured 3-hour interactive sessions one week apart. Eight PACE workshops were held from February 2007 to April 2008 for intervention group GPs. Attendance was set at a maximum of 15 GPs per workshop. The specific aims of the PACE workshops were to improve GP practice in the following key areas: appropriate use of medications, writing an asthma action plan, communication between patient and doctor to improve adherence and patient education and giving instructions on the correct use of aerosol delivery devices.
Intervention code [1] 1179 0
Other interventions
Comparator / control treatment
General practitioners (GPs) were randomly allocated to be wait listed to receive the PACE Australia workshops after patients have had 12 months follow up.
Control group
Active

Outcomes
Primary outcome [1] 2297 0
The proportion of paediatric asthma patients having a written Asthma Action Plan
Timepoint [1] 2297 0
Measured at baseline and at 12 months follow up post intervention.
Secondary outcome [1] 4002 0
Process outcomes were assessed at baseline and at 12 months follow up using validated questionnaires: (1) GP communication and teaching behaviour ; (2) GP adherence to National Asthma Council paediatric asthma management guidelines ; (3) Proportion of children who have completed the Asthma Cycle of Care item numbers;
Timepoint [1] 4002 0
Measured at baseline and at 12 months follow up post intervention.
Secondary outcome [2] 4003 0
Children's outcomes were collected over 12 months by telephone interviews: (1) Medication use ; (2) Number of unscheduled and scheduled consultations ; (3) Days missed from school or child care ; (4) Satisfaction with care provided by the GP.
Timepoint [2] 4003 0
Measured at baseline and at 12 months follow up post intervention.

Eligibility
Key inclusion criteria
GPs:All interested GPs in the Western & Central Sydney Area. The inclusion criteria for families were a child between the ages of 2 and 14 years with a diagnosis of asthma; only one child per family was eligible to participate and a level of English fluency was necessary to enable participation in telephone-administered questionnaires.
Minimum age
2 Years
Maximum age
14 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Exclusion criteria: only one child per family; parents who aren't fluent in English for interviewing purpose.

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Use of an independent body to generate the randomisation sequence by using minimisation to balance participant numbers over three levels (gender; Division of General Practice; FRACGP membership).
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer generated random number sequence.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Double blinded: Family (patient) participants, data analyst
Phase
Phase 3
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
17/07/2006
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
360
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 1805 0
Government body
Name [1] 1805 0
Chronic Disease Programs Section, Chronic Disease Branch, Mental Health and Chronic Disease Division, Australian Government Department of Health and Ageing
Country [1] 1805 0
Australia
Primary sponsor type
University
Name
Primary Health Care Education & Research Unit, Faculty of Medicine, University of Sydney
Address
Westmead Hospital, PO Box 533, Westmead NSW 2145
Country
Australia
Secondary sponsor category [1] 1625 0
None
Name [1] 1625 0
Nil
Address [1] 1625 0
Country [1] 1625 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 3370 0
Sydney West Area Health Service-Westmead Hospital
Ethics committee address [1] 3370 0
Ethics committee country [1] 3370 0
Australia
Date submitted for ethics approval [1] 3370 0
Approval date [1] 3370 0
27/06/2006
Ethics approval number [1] 3370 0
2006/4/4/11(2334)
Ethics committee name [2] 3371 0
University of Sydney
Ethics committee address [2] 3371 0
Ethics committee country [2] 3371 0
Australia
Date submitted for ethics approval [2] 3371 0
Approval date [2] 3371 0
27/07/2006
Ethics approval number [2] 3371 0
9379
Ethics committee name [3] 258301 0
Sydney South West Area Health Service-Royal Prince Alfred Hospital
Ethics committee address [3] 258301 0
Ethics committee country [3] 258301 0
Australia
Date submitted for ethics approval [3] 258301 0
Approval date [3] 258301 0
17/10/2007
Ethics approval number [3] 258301 0
X07-0024

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 35291 0
Address 35291 0
Country 35291 0
Phone 35291 0
Fax 35291 0
Email 35291 0
Contact person for public queries
Name 10368 0
Dr Smita Shah
Address 10368 0
Primary Health Care Education and Research Unit, University of Sydney, Westmead Hospital PO Box 533 Westmead NSW 2145
Country 10368 0
Australia
Phone 10368 0
+61 2 98456505
Fax 10368 0
+61 2 98455310
Email 10368 0
[email protected]
Contact person for scientific queries
Name 1296 0
Dr Smita Shah
Address 1296 0
Primary Health Care Education and Research Unit, University of Sydney, Westmead Hospital PO Box 533 Westmead NSW 2145
Country 1296 0
Australia
Phone 1296 0
+61 2 98456505
Fax 1296 0
+61 2 98455310
Email 1296 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.